MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 1.070
0.00 (0.00%)
Nov 12, 2026, 9:23 AM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €20.16 million as of November 11, 2026. It is the 35,931st most valuable company in the world and the 445th biggest in France. Its market cap has decreased by 67.05% in one year.
Market Cap
20.16M
Enterprise Value
26.84M
Revenue
3.18M
Global Rank
Country Rank
#445 France
PE Ratio
n/a
ChartMarket Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 20.16M, a decrease of -84.81%. That is a compound annual growth rate of -31.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 20.16M | -73.97% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| THX Pharma Société Anonyme | 49.45M |
| OSE Immunotherapeutics | 40.55M |
| Fermentalg | 37.85M |
| Nicox | 25.56M |
| GenSight Biologics | 18.06M |
| genOway Société anonyme | 17.24M |
| Biophytis | 14.98M |
| Aelis Farma | 12.78M |